LONDON, UK I 04, 2024 I GSK plc (LSE/NYSE: GSK) and Medicines for Malaria Venture (MMV) announced today that the World Health Organization (WHO) has ...

OwlTing Group ("Company"), a global blockchain fintech company, today announced that its unhosted digital wallet solution, OwlPay® Wallet Pro (the "Wallet") has integrated with MoneyGram International ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).